Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
108,380,780
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
14,605,233
-
Shares change
-
+125,336
-
Total reported value, excl. options
-
$276,749,000
-
Value change
-
+$2,035,314
-
Number of buys
-
20
-
Number of sells
-
-11
-
Price
-
$18.95
Significant Holders of Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) as of Q1 2016
39 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q1 2016.
Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,605,233 shares
of 108,380,780 outstanding shares and own 13.48% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (4,191,397 shares), FMR LLC (3,804,279 shares), RA CAPITAL MANAGEMENT, LLC (2,627,719 shares), FRANKLIN RESOURCES INC (1,639,454 shares), Rock Springs Capital Management LP (895,500 shares), Cormorant Asset Management, LLC (647,944 shares), VANGUARD GROUP INC (169,296 shares), BlackRock Fund Advisors (146,957 shares), TURNER INVESTMENTS, L.P. (87,004 shares), and STATE STREET CORP (72,831 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.